Division of Gynecologic Oncology, Massachusetts General Hospital, 55 Fruit St, GRB 4-444, Boston, MA 02114. Email:
Am J Manag Care. 2021 Dec 1;27(12):e420-e425. doi: 10.37765/ajmc.2021.88797.
Hospital at home (HAH) is a health care delivery model that substitutes hospital-level services in the home for inpatient hospitalizations. HAH has been shown to be safe and effective for medical patients but has not been investigated in surgical readmissions. We estimated the potential impact of an HAH program for patients readmitted within 60 days postoperatively and described the characteristics of eligible patients to aid in the design of future programs.
This was a cross-sectional study of 60-day postoperative readmissions at a tertiary care center in 2018.
We identified the number of readmissions that may have been eligible for HAH, collected descriptive information, and estimated the financial margin that could have been generated had eligible readmissions been diverted to HAH.
There were 2366 readmissions within 60 days of surgery in 2018. A total of 731 readmissions met inclusion criteria for HAH (30.1%), accounting for 4152 bed days. Of these readmissions, the most common diagnoses were infection, gastrointestinal complications, and cardiac complications. Patients' home addresses were within 16 miles of the hospital in 447 cases (61.1%). Avoidance of these readmissions and use of the beds for new admissions represented a potential backfill margin of $8.8 million, not incorporating the cost of HAH.
Many 60-day postoperative readmissions may be amenable to HAH enrollment, representing a significant opportunity to improve patient experience and generate hospital revenue. This is of particular interest in the post-COVID-19 era. To maximize their impact, HAH programs should tailor clinical and operational services to this population.
家庭医院(HAH)是一种医疗服务模式,它在家中替代住院治疗提供医院级别的服务。HAH 已被证明对医疗患者是安全有效的,但尚未在手术再入院患者中进行研究。我们评估了 HAH 项目对术后 60 天内再入院患者的潜在影响,并描述了符合条件的患者的特征,以帮助设计未来的项目。
这是 2018 年在一家三级护理中心对术后 60 天再入院患者的横断面研究。
我们确定了可能符合 HAH 条件的再入院人数,收集了描述性信息,并估计了如果将符合条件的再入院患者转至 HAH 可能产生的财务收益。
2018 年,术后 60 天内有 2366 例再入院。共有 731 例再入院符合 HAH 的纳入标准(30.1%),占 4152 个床位日。这些再入院患者中,最常见的诊断是感染、胃肠道并发症和心脏并发症。在 447 例(61.1%)患者中,其家庭住址距离医院在 16 英里以内。避免这些再入院并将床位用于新入院患者,可产生 880 万美元的潜在回补收益,未计入 HAH 成本。
许多术后 60 天的再入院可能适合 HAH 登记,这为改善患者体验和产生医院收入提供了一个重要机会。在后 COVID-19 时代,这一点尤其重要。为了最大限度地发挥其影响,HAH 项目应根据这一人群的特点调整临床和运营服务。